Table 1.
Baseline demographic characteristics of the study patients. Data presented as Mean ± SD. No statistically significant differences were observed between groups except placebo group being slightly older. BMI: Body Mass Index, MI: History of myocardial infarction, CVA: history of Cerebrovascular event, PVD: history of peripheral vascular disease
| N | Placebo N = 28 |
Drug N = 30 |
Combined N = 58 |
P-value | ||
|---|---|---|---|---|---|---|
| Age (years) | 58 | (64.5 ± 8.8) | (58.6 ± 12.0) | (61.4 ± 10.9) | 0.0471 | |
| BMI | 58 | (32.2 ± 7.5) | (32.9 ± 8.7) | (32.6 ± 8.0) | 0.971 | |
| Gender | Male | 58 | 57% (16) | 53% (16) | 55% (32) | 0.772 |
| Female | 43% (12) | 47% (14) | 45% (26) | |||
| Race | White | 58 | 93% (26) | 93% (28) | 93% (54) | 0.942 |
| Black | 7% (2) | 7% (2) | 7% (4) | |||
| Diabetic status | Non-Diabetic | 58 | 43% (12) | 43% (13) | 43% (25) | 0.972 |
| Diabetic | 57% (16) | 57% (17) | 57% (33) | |||
| Weight (kg) | 58 | (93 ± 22) | (98 ± 29) | (95 ± 26) | 0.781 | |
| Blood | Systolic | 58 | 135 ± 17 | 140 ± 14 | 138 ± 16 | 0.331 |
| Pressure | Diastolic | 58 | 71 ± 11 | 76 ± 10 | 73 ± 11 | 0.131 |
| MI | 58 | 29% | 10% | 19% | 0.12 | |
| CVA | 58 | 11% | 10% | 10% | 0.92 | |
| PVD | 58 | 11% | 10% | 10% | 0.92 |
Tests used:
1
Wilcoxon test;
2
Pearson test